Toll Free: 1-888-638-4847
Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, PA 19020
Telephone: (215) 638-4847
Facsimile: (215) 638-4867
Speak to a Lawyer, Not a Receptionist!
Celgene Corporation (NASDAQ: CELG)
Copyright © 2006-2018 Law Offices of Howard G. Smith
This lawsuit is for anyone who acquired securities in Celgene Corporation (NASDAQ: CELG) from September 12, 2016 through February 27, 2018.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, during the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors into believing that the FDA would approve its NDA for Ozanimod as a treatment for multiple sclerosis despite knowing that the FDA would not approve the drug because the Company had given the FDA insufficient data to determine whether the drug is safe or effective.

On February 27, 2018, Celgene announced that the FDA had rejected the Company’s NDA for Ozanimod and stated that it had received a refusal-to-file letter from the FDA which advised the Company that the FDA had “determined that the nonclinical and clinical pharmacology sections in the NDA were insufficient to permit a complete review.” On this news, the price of the Company's stock dropped precipitously on unusually heavy trading volume

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Celgene Corporation (NASDAQ: CELG) from September 12, 2016 through February 27, 2018 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.
Case Summary
Join the Class Action
First Name: *
Last Name: *
Middle Initial:
If Representing an Institution, Name of Institution:
If Representing an Institution, Position at Institution:
Mailing Address: *
City: *
State: *
Zip Code:
Country: *
Facsimile #:
Phone #: *
Email *
I, the Plaintiff, certify that:
1.  I have reviewed the Complaint and authorized its filing.

2.  Plaintiff did not purchase the security that is the subject of this
     action, at the direction of plaintiff's counsel or in order to   
     participate in any private action arising under this title.

3.  I am willing to serve as a representative party on behalf of a class
     and will testify at deposition and trial, if necessary.

4.  My transactions in the securities, which are the subject of this 
     action, during the Class Period set forth in the Complaint are as
     follows:
Enter share information:
Read the Complaint
See Press Release
Shares Purchased:
Type of Security:
# of Shares:*
Buy Date:*
Price per Share:*
Shares Sold:
Type of Security:
Sell Date:
# of shares:
Price per share:
5.  I have not served as a representative party on behalf of a class
     under the federal security laws during the last three years, except
     if detailed below.
6.  I will not accept any payment for serving as a representative party,
     except to receive my pro rata share of any recovery or as ordered
     or approved by the court including the award to a representative
     plaintiff of reasonable costs and expenses (including lost wages)
     directly relating to the representation of the class.
Terms:
correct statements.
agreement and retain the Law Offices of Howard G. Smith and its associates to proceed on Plaintiff's behalf, on a contingent fee basis.  If I am executing this agreement on behalf of an institution, I further certify that I am authorized to execute this agreement on behalf of the institution.
*Are you now or were you ever an employee of the
  company?
* I declare under penalty of perjury that the foregoing are true and
* By clicking on the button below, I intend to sign and execute this 
YesNo